GCL
MSAC

Glazer Capital LLC’s Medicus Sciences Acquisition Corp. Class A Ordinary Share MSAC Stock Holding History

Glazer Capital LLC’s Portfolio MSAC Stock Details MSAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-902,871
Closed -$9.09M – 533
2022
Q4 		$9.09M Sell
902,871
-7,511
-0.8% -$74.9K 0.24% 128
2022
Q3 		$9.01M Sell
910,382
-200
-0% -$1.97K 0.17% 189
2022
Q2 		$8.9M Buy
910,582
+474,730
+109% +$4.65M 0.22% 154
2022
Q1 		$4.26M Sell
435,852
-15,160
-3% -$148K 0.12% 187
2021
Q4 		$4.37M Sell
451,012
-2,760
-0.6% -$26.8K 0.11% 238
2021
Q3 		$4.42M Sell
453,772
-305
-0.1% -$2.94K 0.08% 281
2021
Q2 		$4.38M Buy
+454,077
New +$4.44M 0.07% 316

Glazer Capital LLC's MSAC Position: Q1 2023 in Review

Glazer Capital LLC sold out of Medicus Sciences Acquisition Corp. Class A Ordinary Share (MSAC) in Q1 2023, closing a stake of 902,871 shares — an estimated $9.09M sold.

Glazer Capital LLC first reported a position in MSAC in Q2 2021 and held it in 7 quarters. The position peaked at $9.09M in Q4 2022. 0 funds tracked by Wall St. Rank hold MSAC as of Q1 2023.

  • Glazer Capital LLC reported no remaining Medicus Sciences Acquisition Corp. Class A Ordinary Share position as of Q1 2023 after selling out during the quarter.
  • Glazer Capital LLC sold 902,871 Medicus Sciences Acquisition Corp. Class A Ordinary Share shares in Q1 2023, an estimated $9.09M.
  • Glazer Capital LLC first reported a position in Medicus Sciences Acquisition Corp. Class A Ordinary Share in Q2 2021 and held it in 7 quarters.
  • Glazer Capital LLC's Medicus Sciences Acquisition Corp. Class A Ordinary Share position peaked at $9.09M in Q4 2022.
  • 0 funds tracked by Wall St. Rank held Medicus Sciences Acquisition Corp. Class A Ordinary Share as of Q1 2023.

Based on Glazer Capital LLC's 13F filing for Q1 2023, filed 15 May 2023.